Caris Life Sciences (CAI) Net Cash Flow (2024 - 2026)

Caris Life Sciences' Net Cash Flow history runs 3 years deep, the most recent figure standing at $23.4 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 171.34% year-over-year to $23.4 million; the TTM figure through Mar 2026 stood at $788.0 million (up 643.83% YoY), while the FY2025 annual figure was $731.9 million, up 9020.05% from the prior year.
• Net Cash Flow was $23.4 million for Q1 2026 at Caris Life Sciences, down from $43.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $687.3 million in Q2 2025 to a low of -$71.2 million in Q3 2024.
• Historically, Net Cash Flow has averaged $91.9 million across 3 years, with a median of $23.4 million in 2026.
• Biggest YoY gain for Net Cash Flow was 205.13% in 2025; the steepest drop was 148.1% in 2025.
• A 3-year view of Net Cash Flow shows it stood at -$41.0 million in 2024, then jumped by 205.13% to $43.1 million in 2025, then plunged by 45.79% to $23.4 million in 2026.
• The last three Net Cash Flow figures came in at $23.4 million (Q1 2026), $43.1 million (Q4 2025), and $34.2 million (Q3 2025), per Business Quant data.